RIPK3, a central factor of necroptosis, coordinates fatty acid metabolism and hepatocarcinogenesis in tumor-associated macrophages, highlighting a potential strategy that can be used to target immunometabolism in HCC16. Here, RIPK3 is linked to neoplasm.